[ACRS] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
03-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 16.91%
YoY- -0.57%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -14,838 -12,559 -11,475 -10,694 -12,871 -13,039 -4,714 114.92%
Tax 0 0 -40 0 0 0 -33 -
NP -14,838 -12,559 -11,475 -10,694 -12,871 -13,039 -4,714 114.92%
Tax Rate - - - - - - - -
Total Cost 14,838 12,559 11,475 10,694 12,871 13,039 4,714 114.92%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS -0.56 -0.48 -0.49 -0.50 -0.62 -0.65 -0.26 66.85%
EPS Diluted -0.56 -0.48 -0.49 -0.50 -0.62 -0.65 -0.26 66.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.